StethoMe has announces the European roll out of its medical diagnostics device after signing major deals with telemedicine providers MaQuestionMedicale in France and Home Doctor in Spain.
After successful trials, StethoMe will now combine its smart AI wireless stethoscope with MaQuestionMedicale and Homedoctor’s telemedicine platforms that connect patients with doctors and healthcare professionals.
With both deals now signed, patients will have access to StethoMe in France and Spain within the coming weeks. StethoMe is also in discussions with other major telemedicine providers across Europe and will be scaling up its operations to support new deals being signed.
StethoMe’s smart wireless stethoscope capable of detecting, classifying and analysing pathological sounds within the lungs using medical-grade precision. The device works alongside an which guides patients through each examination. Results are shared directly with a doctor - through MaQuestionMedicale and Homedoctor - who then consult as to whether that person needs to visit a doctor in person or can remain at home under close supervision.
Wojciech Radomski, CEO, StethoMe, said: “Our team of technological and medical experts have devoted the last five years of R&D efforts to the creation of a smart wireless stethoscope that is designed to recognise early signs of respiratory issues in children and adults. At a time where medical services are under strain across the globe due to the COVID-19 pandemic, we believe the deals we have signed with MaQuestionMedicale and HomeDoctor will contribute towards lessening the burden on healthcare systems and reduce the unnecessary spread of the disease, whilst ensuring patients that need care get it.”
StethoMe is also developing remote lung and heart examinations for elderly patients with underlying medical conditions.
Juan Lariz, CEO, HomeDoctor, said: “As a company providing telemedicine services, we want to increase the efficiency and effectiveness of our services. Adding the ability to perform remote lung examinations supported by AI is a very important functionality - and in the case of the COVID-19 epidemic is crucial. We’re excited to work closely with StethoMe.”
To reach the point where its diagnostics device is now commercially available, StethoMe has been awarded full certification from the EU for its device and AI algorithms, and has been researched and tested by a number of medical organisations.
Prof. Catherine Van Der Straeten, head of the Health Innovation and Research Institute Ghent University Hospital added: “StethoMe is a solution that has been proven to help with the early screening of patients with lung problems from their home. In recent weeks, this has become even more important during the COVID-19 crisis situation across Europe. Telemedicine and the transfer of diagnostics to the patient’s home is the future, and the possibility of lung monitoring in patients with chronic diseases like COPD or asthma is a huge benefit. Thanks to solutions like StethoMe, telemedicine is constantly evolving.”
